$13.46
00.00%
Last update: 4:00 PM
15 minutes delayed
Day One Biopharmaceutical
DAWNNASDAQ
Day One Biopharmaceutical (DAWN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDay One Biopharmaceutical (NASDAQ:DAWN) Stock Quotes, Forecast and News Summary
Day One Biopharmaceutical Stock (NASDAQ: DAWN) stock price, news, charts, stock research, profile.
| Open | $13.58 |
| Close | - |
| Volume / Avg. | 147.62K / 1.18M |
| Day Range | 13.25 - 13.68 |
| 52 Wk Range | 9.67 - 18.07 |
| Market Cap | $1.18B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 14.7% |
| Days to Cover | 11.93 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Day One Biopharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated toward...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Day One Biopharmaceutical (DAWN) stock?
You can purchase shares of Day One Biopharmaceutical (NASDAQ:DAWN) through any online brokerage.
Who are Day One Biopharmaceutical (DAWN) competitors?
Other companies in Day One Biopharmaceutical’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Prothena Corp (NASDAQ:PRTA).
What is the target price for Day One Biopharmaceutical (DAWN) stock?
There is no analysis for Day One Biopharmaceutical.
What is the forecast for Day One Biopharmaceutical (DAWN) stock?
Day One Biopharmaceutical has a consensus price target of $30.78.
Current stock price for Day One Biopharmaceutical (DAWN)?
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $13.46 last updated July 2, 2024 at 4:00 PM EDT.
Does Day One Biopharmaceutical (DAWN) pay a dividend?
There are no upcoming dividends for Day One Biopharmaceutical.
When is Day One Biopharmaceutical (NASDAQ:DAWN) reporting earnings?
Day One Biopharmaceutical’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Day One Biopharmaceutical (DAWN) going to split?
There is no upcoming split for Day One Biopharmaceutical.
What sector and industry does Day One Biopharmaceutical (DAWN) operate in?
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.